Genomes and Genes
Gene Symbol: MYH9
Description: myosin heavy chain 9
Alias: BDPLT6, DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHC-IIA, NMMHCA, myosin-9, cellular myosin heavy chain, type A, myosin, heavy chain 9, non-muscle, non-muscle myosin heavy chain 9, non-muscle myosin heavy chain A, non-muscle myosin heavy chain IIa, non-muscle myosin heavy polypeptide 9, nonmuscle myosin heavy chain II-A
Publications205 found, 100 shown here
- Mts1 regulates the assembly of nonmuscle myosin-IIAZhong hua Li
Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA
Biochemistry 42:14258-66. 2003..Altogether, these observations are consistent with mts1 regulating myosin IIA assembly by monomer sequestration and suggest that mts1 regulates cell shape and motility through the modulation of myosin-IIA function...
- Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1Jun Arii
Division of Viral Infection, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Minato ku, Tokyo 108 8639, Japan
Nature 467:859-62. 2010..The identification of NMHC-IIA as an HSV-1 entry receptor and the involvement of NM-IIA regulation in HSV-1 infection provide an insight into HSV-1 entry and identify new targets for antiviral drug development...
- Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migrationNicole A Morin
Department of Surgery, Rhode Island Hospital and Brown Medical School, Providence, RI 02903, USA
J Exp Med 205:195-205. 2008..Here, we show that nonmuscle myosin heavy chain IIA (MyH9) is recruited to LFA-1 at the uropod of migrating T lymphocytes, and inhibition of the association of MyH9 with LFA-..
- Nonmuscle myosin IIA is required for lamellipodia formation through binding to WAVE2 and phosphatidylinositol 3,4,5-triphosphateShigeru Morimura
Molecular Cell Biology Division, Kanagawa Cancer Center Research Institute, Yokohama 241 0815, Japan
Biochem Biophys Res Commun 404:834-40. 2011..We identified p250 as nonmuscle myosin IIA heavy chain (MYH9) by mass spectrometry and immunoblot analysis using anti-MYH9 antibody...
- Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosinR L Shoeman
Max Planck Institut für Zellbiologie, Ladenburg, Federal Republic of Germany
Am J Pathol 142:221-30. 1993..Nonmuscle myosin heavy chains were also cleaved by this enzyme in vitro. These data demonstrate that this protease can cause alterations in muscle cell ultrastructure in vitro that may be of clinical relevance in infected individuals...
- Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variationCheryl A Winkler
Scientific Applications International Corporation Frederick, Inc, Laboratory of Genomic Diversity, Center for Cancer Research, National Cancer Institute Frederick, National Institutes of Health, Frederick, MD, USA
Semin Nephrol 30:111-25. 2010..Admixture mapping identified genetic variants in the nonmuscle myosin heavy chain 9 gene (MYH9) as having a major influence on both FSGS and human immunodeficiency virus-associated collapsing glomerulopathy, ..
- The MYH9/APOL1 region and chronic kidney disease in European-AmericansConall M O'Seaghdha
National Heart, Lung and Blood Institute s Framingham Heart Study and Center for Population Studies, Framingham, MA, USA
Hum Mol Genet 20:2450-6. 2011Polymorphisms in the MYH9 and adjacent APOL1 gene region demonstrate a strong association with non-diabetic kidney disease in African-Americans...
- Polymorphisms in MYH9 are associated with diabetic nephropathy in European AmericansJessica N Cooke
Program in Molecular Medicine and Translational Science, Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston Salem, NC, USA
Nephrol Dial Transplant 27:1505-11. 2012Polymorphisms in the non-muscle myosin IIA gene (MYH9) are associated with focal segmental glomerulosclerosis (FSGS) and non-diabetic end-stage renal disease (ESRD) in African Americans and FSGS in European Americans...
- Glomerular MYH9 expression is reduced by HIV-1Thomas Hays
Mount Sinai School of Medicine, Department of Medicine, New York, New York, USA
AIDS 26:797-803. 2012..Given that loss of MYH9 function causes a Mendelian renal disease, we hypothesized that renal expression of MYH9 is down-regulated by HIV-1 ..
- Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomesM Simons
Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892
Circ Res 69:530-9. 1991..Comparison of this sequence to cDNA clones encoding the amino-terminal one third of the NMMHC-B sequence (amino acids 58-718) shows them to be 89% identical at the amino acid level and 74% identical at the nucleotide level...
- Cellular myosin heavy chain in human leukocytes: isolation of 5' cDNA clones, characterization of the protein, chromosomal localization, and upregulation during myeloid differentiationL E Toothaker
Hematology Oncology Division, Beth Israel Hospital, Boston, MA 02215
Blood 78:1826-33. 1991..This cellular myosin heavy chain may be a major contractile protein responsible for movement in myeloid cell lines because no mRNA for sarcomeric myosin heavy chain is detected in these cells...
- Differential localization of myosin-II isozymes in human cultured cells and blood cellsP Maupin
Department of Cell Biology and Anatomy, Johns Hopkins Medical School, Baltimore, MD 21205 2196
J Cell Sci 107:3077-90. 1994..The superimposition of these small spots concentrated in the cleavage furrow produces the intense, uniform staining observed in conventional micrographs of whole cells...
- Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome ConsortiumM Seri
Laboratory of Molecular Genetics, Institute G Gaslini, Genoa, Italy
Nat Genet 26:103-5. 2000The autosomal dominant, giant-platelet disorders, May-Hegglin anomaly (MHA; MIM 155100), Fechtner syndrome (FTNS; MIM 153640) and Sebastian syndrome (SBS), share the triad of thrombocytopenia, large platelets and characteristic leukocyte ..
- Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomalyM J Kelley
Department of Medicine, Duke University, Durham, North Carolina, USA
Nat Genet 26:106-8. 2000..Here we screen a candidate gene in this region, encoding non-muscle myosin heavy chain A (MYH9), for mutations in ten families...
- Conditional expression of a truncated fragment of nonmuscle myosin II-A alters cell shape but not cytokinesis in HeLa cellsQ Wei
Laboratory of Molecular Cardiology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
Mol Biol Cell 11:3617-27. 2000....
- Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromesK E Heath
Department of Human Genetics, Mount Sinai School of Medicine, New York, NY 10029, USA
Am J Hum Genet 69:1033-45. 2001..mutations, K371N and R702H, as well as the recently identified MYH9 mutation, R705H, which results in DFNA17, were modeled on the basis of X-ray crystallographic data...
- Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromesChristelle Arrondel
INSERM U 423, Universite Rene Descartes, Hopital Necker Enfants Malades, Paris, France
J Am Soc Nephrol 13:65-74. 2002Mutations in the MYH9 gene, which encodes the nonmuscle myosin heavy chain IIA, have been recently reported in three syndromes that share the association of macrothrombocytopenia (MTCP) and leukocyte inclusions: the May-Hegglin anomaly ..
- Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromesMaria D'Apolito
Servizio di Genetica Medica, IRCCS Ospedale CSS, I 71013 San Giovanni Rotondo, Foggia, Italy
Gene 286:215-22. 2002Mutations in the non-muscle myosin heavy chain IIA gene (MYH9) are responsible for May-Hegglin anomaly, Sebastian, Fechtner and Epstein syndromes...
- Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutationsShinji Kunishima
Japanese Red Cross Aichi Blood Center, Seto, Japan
Lab Invest 83:115-22. 2003..disorders are caused by mutations in the same gene, the MYH9, which encodes the nonmuscle myosin heavy chain-A (NMMHCA)...
- Myosin is an in vivo substrate of the protein tyrosine phosphatase (SHP-1) after mIgM cross-linkingTakeshi Baba
Research Institute for Biological Sciences, Tokyo University of Science, 2669 Yamazaki, Noda, 278 0022, Chiba, Japan
Biochem Biophys Res Commun 304:67-72. 2003..Thus, myosin is a direct SHP-1 substrate in B cells. The results suggest that SHP-1 plays a critical role in the reorganization of cytoskeletal architecture mediated via BCR stimulation...
- A single class II myosin modulates T cell motility and stopping, but not synapse formationJordan Jacobelli
Department of Pathology, University of California at San Francisco, 513 Parnassus Ave, San Francisco, California 93143, USA
Nat Immunol 5:531-8. 2004..Here we show that nonmuscle myosin heavy chain IIA, or MyH9, is the only class II myosin expressed in T cells and is associated with the uropod during crawling...
- Regulation of myosin-IIA assembly and Mts1 binding by heavy chain phosphorylationNatalya G Dulyaninova
Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA
Biochemistry 44:6867-76. 2005....
- Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related diseaseMonica Marini
Laboratory of Molecular Genetics, G Gaslini Institute, 16147 Genova, Italy
Int J Mol Med 17:729-36. 2006..This argument is relevant not only to cell physiology, but also to human pathology since mutations of the MYH9 gene encoding non-muscle myosin heavy chain II A (NMMHC-A) cause MYH9-related disease (MYH9-RD), an autosomal ..
- Rho kinase differentially regulates phosphorylation of nonmuscle myosin II isoforms A and B during cell rounding and migrationJoshua C Sandquist
Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA
J Biol Chem 281:35873-83. 2006..Our data suggest that the myosin IIA and IIB isoforms are regulated by different signaling pathways to perform distinct cellular activities and that myosin IIA is preferentially required for Rho-mediated contractile functions...
- Myosin IIA regulates cell motility and actomyosin-microtubule crosstalkSharona Even-Ram
Craniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research NIDCR, National Institutes of Health, Bethesda, MD 20892, USA
Nat Cell Biol 9:299-309. 2007..We conclude that myosin IIA negatively regulates cell migration and suggest that it maintains a balance between the actomyosin and microtubule systems by regulating microtubule dynamics...
- Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cellsNatalya G Dulyaninova
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Mol Biol Cell 18:3144-55. 2007..In contrast, cells expressing the S1943A mutant exhibited reduced migration and lamellipod extension. These observations support a direct role for myosin-IIA heavy-chain phosphorylation in mediating motility and chemotaxis...
- Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related diseaseAlessandro Pecci
Department of Internal Medicine, University of Pavia and Istituto di Ricovero e Cura a Carattere Scientifico IRCCS, Policlinico San Matteo Foundation, Pavia, Italy
Hum Mutat 29:409-17. 2008b>MYH9-related disease (MYH9-RD) is a rare autosomal-dominant disorder caused by mutations in MYH9, the gene for the heavy chain of nonmuscle myosin IIA (NMMHC-IIA)...
- MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and functionYan Li
Laboratory of Molecular Otology, Department of Otolaryngology, New York University School of Medicine, New York, New York 10016, USA
Cell Motil Cytoskeleton 65:393-405. 2008b>MYH9 encodes a class II nonmuscle myosin heavy chain-A (NMHC-IIA), a widely expressed 1960 amino acid polypeptide, with translated molecular weight of 220 kDa...
- Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cellsRichard K Tsai
Biophysical Engineering Laboratory, University of Pennsylvania, Philadelphia, PA 19104, USA
J Cell Biol 180:989-1003. 2008..A point mutation turns off this motor's contribution to phagocytosis, suggesting that self-recognition inhibits contractile engulfment...
- MYH9 is associated with nondiabetic end-stage renal disease in African AmericansW H Linda Kao
Department of Epidemiology, School of Medicine and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21287, USA
Nat Genet 40:1185-92. 2008..2 to 0.6) in the gene encoding nonmuscle myosin heavy chain type II isoform A (MYH9) were associated with two to four times greater risk of nondiabetic ESRD and accounted for a large proportion of ..
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisJeffrey B Kopp
Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
Nat Genet 40:1175-84. 2008..2 and a peak lod of 12.4 centered on MYH9, a functional candidate gene expressed in kidney podocytes...
- Multiple regulatory steps control mammalian nonmuscle myosin II assembly in live cellsMark T Breckenridge
Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
Mol Biol Cell 20:338-47. 2009..This work furthermore offers cellular insights that help explain platelet and leukocyte defects associated with R1933-stop alleles of patients afflicted with human MYH9-related disorder.
- Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN studyBarry I Freedman
Section on Nephrology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1053, USA
Am J Nephrol 29:626-32. 2009b>MYH9 is a podocyte-expressed gene encoding nonmuscle myosin IIA that is associated with idiopathic and human immunodeficiency virus-associated focal segmental glomerulosclerosis (FSGS) and hypertensive end-stage renal disease in African ..
- Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African AmericansBarry I Freedman
Internal Medicine Nephrology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1053, USA
Kidney Int 75:736-45. 2009..association with idiopathic and HIV-related focal segmental glomerulosclerosis and non-muscle myosin heavy chain 9 (MYH9) gene polymorphisms in this ethnic group, we tested for MYH9 associations in a variety of kidney diseases...
- Genome-wide linkage analysis of serum creatinine in three isolated European populationsCristian Pattaro
Institute of Genetic Medicine, European Academy Bozen Bolzano EURAC, Bolzano, Italy
Kidney Int 76:297-306. 2009..and hypertension, was detected over a region containing the non-muscle myosin heavy chain type II isoform A (MYH9) gene (LOD score=3.52)...
- Identification of three in-frame deletion mutations in MYH9 disorders suggesting an important hot spot for small rearrangements in MYH9 exon 24Koji Miyazaki
Department of Hematology, Kitasato University School of Medicine, 1 15 1 Kitasato, Sagamihara, 228 8555 Kanagawa, Japan
Eur J Haematol 83:230-4. 2009b>MYH9 disorders include hereditary macrothrombocytopenias with leukocyte inclusion bodies...
- Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRDBarry I Freedman
1Internal Medicine Nephrology, 2Biochemistry, 3Biostatistical Sciences, Wake Forest University School of Medicine, Winston Salem, NC, USA
Nephrol Dial Transplant 24:3366-71. 2009Although MYH9 is strongly associated with biopsy-proven idiopathic and HIV-associated focal segmental glomerulosclerosis (FSGS) and clinically diagnosed 'hypertension-associated' end-stage renal disease (ESRD) in African Americans, its ..
- The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family StudyNora Franceschini
Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27514, USA
Hum Genet 127:295-301. 2010..Recent research has identified associations of polymorphisms in the myosin heavy chain type II isoform A (MYH9) gene with hypertensive CKD in African-Americans...
- Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15George W Nelson
Laboratory of Genomic Diversity, SAIC Frederick, Inc, NCI Frederick, Frederick, MD, USA
Hum Mol Genet 19:1805-15. 2010Admixture mapping recently identified MYH9 as a susceptibility gene for idiopathic focal segmental glomerulosclerosis (FSGS), HIV-associated nephropathy (HIVAN) and end-stage kidney disease attributed to hypertension (H-ESKD) in African ..
- Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorderAnna Savoia
Medical Genetics, Department of Reproductive and Developmental Sciences, IRCCS Burlo Garofolo, University of Trieste, Trieste, Italy
Thromb Haemost 103:826-32. 2010b>MYH9-related disease ( MYH9-RD) is an autosomal dominant thrombocytopenia with giant platelets variably associated with young-adult onset of progressive sensorineural hearing loss, presenile cataract, and renal damage...
- Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal diseaseTakashi Sekine
Faculty of Medicine, Department of Pediatrics, The University of Tokyo, Tokyo, Japan
Kidney Int 78:207-14. 2010..underlie rare autosomal dominant diseases such as May-Hegglin anomaly, and Sebastian, Epstein (EPS), and Fechtner (FTNS) syndromes that are characterized by macrothrombocytopenia and cytoplasmic inclusion bodies in granulocytes...
- The spectrum of MYH9-associated nephropathyMeredith A Bostrom
Department of Biochemistry, Wake Forest University School of Medicine, Winston Salem, NC 27157 1053, USA
Clin J Am Soc Nephrol 5:1107-13. 2010..Recently, polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) have been associated with nondiabetic kidney diseases in African- and European-derived populations...
- In vitro expression and characterization of MYH9 mutant alleles linked to hereditary hearing lossCalvin C Wei
Department of Otolaryngology, New York University School of Medicine, New York, NY 10016, USA
Otolaryngol Head Neck Surg 142:699-703. 2010To assess whether MYH9 mutant alleles linked to hereditary hearing loss induce disruption of cellular functions and associated phenotype following transient expression within cultured human cell lines.
- The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African AmericansBarry I Freedman
Section on Nephrology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1053, USA
Am J Nephrol 32:66-72. 2010..Since MYH9 underlies approximately 40% of end-stage renal disease (ESRD) in AA, we tested for genetic association with LN.
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneShay Tzur
Ruth and Bruce Rappaport Faculty of Medicine and Research Institute, Technion Israel Institute of Technology, Haifa, Israel
Hum Genet 128:345-50. 2010b>MYH9 has been proposed as a major genetic risk locus for a spectrum of nondiabetic end stage kidney disease (ESKD)...
- A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9Giulio Genovese
Renal Division, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Kidney Int 78:698-704. 2010Genetic variation at the MYH9 locus is linked to the high incidence of focal segmental glomerulosclerosis (FSGS) and non-diabetic end-stage renal disease among African Americans...
- Mechanism of the Ca²+-dependent interaction between S100A4 and tail fragments of nonmuscle myosin heavy chain IIASandip K Badyal
Department of Biochemistry, University of Leicester, Henry Wellcome Building, Lancaster Road, Leicester LE1 9HN, UK
J Mol Biol 405:1004-26. 2011....
- Renal manifestations of patients with MYH9-related disordersKyoung Hee Han
Department of Pediatrics, Seoul National University Children s Hospital, 101 Daehang no, Jongno gu, Seoul, 110 744, South Korea
Pediatr Nephrol 26:549-55. 2011b>MYH9-related disorders are a group of autosomal, dominantly inherited disorders caused by mutations of the MYH9 gene, which encodes the non-muscle myosin heavy chain IIA (NMMHC-IIA)...
- Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with the progression of IgA nephropathy in ChineseWenrong Cheng
Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, and Key Laboratory of Renal Disease, Ministry of Health of China, Beijing 100034, People s Republic of China
Nephrol Dial Transplant 26:2544-9. 2011..A recent genome-wide association study (GWAS) indicated that the MYH9 gene was significantly associated with non-diabetic ESRD in African-Americans and also influenced kidney function ..
- MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancerShuli Liang
State Key Laboratory of Cancer Biology and Institute of Digestive Diseases, Xijing Hospital of Digestive Diseases, Xi an, China
PLoS ONE 6:e18409. 2011..In this study, we investigate whether let-7f acts as a tumor suppressor to inhibit invasion and metastasis in gastric cancers...
- Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African AmericansBarry I Freedman
Section on Nephrology, Department of Internal Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina, USA
PLoS Genet 7:e1002150. 2011Single nucleotide polymorphisms (SNPs) in MYH9 and APOL1 on chromosome 22 (c22) are powerfully associated with non-diabetic end-stage renal disease (ESRD) in African Americans (AAs)...
- Two functional S100A4 monomers are necessary for regulating nonmuscle myosin-IIA and HCT116 cell invasionReniqua P House
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, United States
Biochemistry 50:6920-32. 2011....
- MYH9 and APOL1 are both associated with sickle cell disease nephropathyAllison E Ashley-Koch
Center for Human Genetics, Duke University Medical Center, Durham, NC 27710, USA allison ashleykoch duke edu
Br J Haematol 155:386-94. 2011..The myosin, heavy chain 9, non-muscle (MYH9) and apolipoprotein L1 (APOL1) genes have been associated with risk for focal segmental glomerulosclerosis and end-..
- Nonmuscle myosin IIA is associated with poor prognosis of esophageal squamous cancerZ K Xia
Department of Cardio Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China
Dis Esophagus 25:427-36. 2012..021). In addition, MYH9 SiRNA was transfected into esophageal squamous cancer cell line (KYSE-510) to study the role of myosin IIA in cell ..
- Role of MYH9 and APOL1 in African and non-African populations with lupus nephritisC P Lin
Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA
Genes Immun 13:232-8. 2012..Multiple studies reported associations between renal diseases and variants in the non-muscle myosin heavy chain 9 (MYH9) and the neighboring apolipoprotein L 1 (APOL1) genes...
- Polymorphisms in the non-muscle myosin heavy chain gene (MYH9) are associated with lower glomerular filtration rate in mixed ancestry diabetic subjects from South AfricaTandi Edith Matsha
Department of Biomedical Sciences, Faculty of Health and Wellness Science, Cape Peninsula University of Technology, Cape Town, South Africa
PLoS ONE 7:e52529. 2012Though single nucleotide polymorphisms (SNPs) in the non-muscle myosin gene (MYH9) have been reported to explain most of the excess risk of nondiabetic chronic kidney disease (CKD), in African-Americans, some studies have also shown ..
- Effect of Mts1 on the structure and activity of nonmuscle myosin IIH L Ford
Department of Biochemistry and Cancer Center, University of Rochester, 601 Elmwood Avenue, Rochester, New York 14642, USA
Biochemistry 36:16321-7. 1997..The data demonstrate an effect of Mts1 on both myosin structure and function, and suggest a route through which Mts1 affects motility as well as metastasis...
- Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusionsS Kunishima
First Department of Internal Medicine, Nagoya University School of Medicine, Japan
J Hum Genet 46:722-9. 2001..with leukocyte inclusions, May-Hegglin anomaly (MHA), Sebastian syndrome (SBS), and Fechtner syndrome (FTNS), are rare platelet disorders characterized by a triad of giant platelets, thrombocytopenia, and characteristic Dö..
- MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illnessMarco Seri
Laboratorio di Genetica Molecolare, Istituto G Gaslini, Genova, Italy
Medicine (Baltimore) 82:203-15. 2003..Mutations in the MYH9 gene encoding for the nonmuscle myosin heavy chain IIA (NMMHC-IIA) have been identified in all these syndromes...
- Interaction of metastasis-inducing S100A4 protein in vivo by fluorescence lifetime imaging microscopyShu Zhang
Cancer and Polio Research Fund Laboratories, School of Biological Sciences, University of Liverpool, Liverpool, L69 7ZB, UK
Eur Biophys J 34:19-27. 2005....
- Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patientsPatrizia Noris
Department of Internal Medicine, IRCCS Policlinico San Matteo University of Pavia, Italy
Haematologica 89:1219-25. 2004..The aim of the present study was to validate this diagnostic algorithm by applying it to a case series of genetic thrombocytopenias...
- Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disordersShinji Kunishima
Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
Blood 111:3015-23. 2008b>MYH9 disorders such as May-Hegglin anomaly are characterized by macrothrombocytopenia and cytoplasmic granulocyte inclusion bodies that result from mutations in MYH9, the gene for nonmuscle myosin heavy chain-IIA (NMMHC-IIA)...
- Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disordersShinji Kunishima
Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
Eur J Haematol 80:540-4. 2008b>MYH9 disorders are autosomal dominant macrothrombocytopenias with leukocyte inclusion bodies. Single point mutations in the protein-coding sequence of the MYH9 gene are the most common cause...
- Non-muscle myosin IIA differentially regulates intestinal epithelial cell restitution and matrix invasionBrian A Babbin
Epithelial Pathobiology Research Unit, Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA
Am J Pathol 174:436-48. 2009..These observations indicate multiple functions for NM IIA, which, along with the regulation of the F-actin cytoskeleton and cell-matrix adhesions, involve previously unrecognized control of intracellular signaling and protein expression...
- Identification of the first duplication in MYH9-related disease: a hot spot for unequal crossing-over within exon 24 of the MYH9 geneDaniela De Rocco
Medical Genetics, Department of Reproductive and Developmental Sciences, Institute for Maternal and Child Health IRCCS Burlo Garofolo, University of Trieste, Via dell Istria 65 1, 34137 Trieste, Italy
Eur J Med Genet 52:191-4. 2009b>MYH9-related disease (MYH9RD) is a rare autosomal dominant disorder caused by mutations in MYH9, the gene encoding the heavy chain of non-muscle myosin IIA...
- Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility geneMarina Nunez
Department of Internal Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27157 1053, USA
Adv Chronic Kidney Dis 17:44-51. 2010..Although polymorphisms in the MYH9 gene on chromosome 22 are strongly associated with HIVAN, as well as with idiopathic focal segmental ..
- African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic AmericansDoron M Behar
Molecular Medicine Laboratory, Rambam Health Care Campus, Haifa 31096, Israel
Hum Mol Genet 19:1816-27. 2010Recent studies identified MYH9 as a major susceptibility gene for common forms of non-diabetic end-stage kidney disease (ESKD)...
- Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in AfricaTaras K Oleksyk
Department of Biology, University of Puerto Rico at Mayaguez, Mayaguez, Puerto Rico
PLoS ONE 5:e11474. 2010b>MYH9 was recently identified as renal susceptibility gene (OR 3-8, p < 10(-8)) for major forms of kidney disease disproportionately affecting individuals of African descent...
- Vertebrate nonmuscle myosin II isoforms rescue small interfering RNA-induced defects in COS-7 cell cytokinesisJianjun Bao
Laboratory of Molecular Cardiology, NHLBI, National Institutes of Health, Bethesda, Maryland 20892, USA
J Biol Chem 280:19594-9. 2005....
- Identification of the first in cis mutations in MYH9 disorderYuji Miyajima
Department of Pediatrics, Anjo Kosei Hospital, Anjo, Aichi, Japan
Eur J Haematol 82:288-91. 2009Here, we report the first in cis mutations in exon 1 of the MYH9 gene in a patient with MYH9 disorder. The patient was a 5-yr-old girl with macrothrombocytopenia and conspicuous cytoplasmic inclusion bodies in neutrophils...
- Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disordersAlessandro Pecci
Department of Internal Medicine, IRCCS San Matteo, University of Pavia, Italy
Br J Haematol 117:164-7. 2002May-Hegglin anomaly (MHA), Sebastian syndrome (SBS) and Fechtner syndrome (FTNS) are autosomal-dominant macrothrombocytopenias with Döhle-like leucocyte inclusions...
- Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutationsAlessandro Pecci
Department of Internal Medicine, University of Pavia, Italy
Hum Mol Genet 14:3169-78. 2005Mutations of MYH9, the gene for non-muscle myosin heavy chain IIA (NMMHC-IIA), cause a complex clinical phenotype characterized by macrothrombocytopenia and granulocyte inclusion bodies, often associated with deafness, cataracts and/or ..
- Induction of nonmuscle myosin heavy chain II-C by butyrate in RAW 264.7 mouse macrophagesDenis B Buxton
Laboratory of Molecular Cardiology, NHLBI, National Institutes of Health, Bethesda, Maryland 20892, USA
J Biol Chem 278:15449-55. 2003..8-Bromo-cGMP had no effect on nonmuscle myosin heavy chain induction, consistent with a cGMP-independent mechanism for nitric oxide-mediated inhibition of nonmuscle myosin heavy chain II-C induction...
- Increased expression of non-muscle myosin heavy chain-B in connective tissue cells of hypertrophic rat urinary bladderR Sjuve
Department of Physiological Sciences, Lund University, Sweden
Cell Tissue Res 304:271-8. 2001..The NM-MHC-B-positive cells could have a role in the production of extracellular matrix and growth factors or be involved in modulation of spontaneous contractile activity...
- Ablation and mutation of nonmuscle myosin heavy chain II-B results in a defect in cardiac myocyte cytokinesisKazuyo Takeda
Laboratory of Molecular Cardiology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1762, USA
Circ Res 93:330-7. 2003..Whereas cardiac myocytes completely ablated for NMHC II-B show enlargement and binucleation, mice expressing as little as 6% of the normal amount of wild-type NMHC II-B in the heart do not show these abnormalities...
- Expression of non-muscle myosin heavy chain in rat heart after immunosuppressive treatmentRita Rezzani
Division of Human Anatomy, Department of Biomedical Sciences and Biotechnologies, University of Brescia, V le Europa 11, 25123, Brescia, Italy
Int Immunopharmacol 6:962-7. 2006..This could be explained as a tentative of cardiac tissue to maintain the structural integrity of intercalated disks and so the contraction/relaxation process...
- Differential expression of non-muscle myosin heavy chain genes during Xenopus embryogenesisN Bhatia-Dey
Laboratory of Molecular Cardiology, National Heart Lung and Blood Institute, Bethesda, MD, USA
Mech Dev 78:33-6. 1998....
- IRF-2 is involved in up-regulation of nonmuscle myosin heavy chain II-A gene expression during phorbol ester-induced promyelocytic HL-60 differentiationMyung Chul Chung
Laboratory of Molecular Cardiology, National Heart, Lung, and Blood Institute NIH, 10 Center Drive, Bethesda, MD 20892, USA
J Biol Chem 279:56042-52. 2004..Together, these results indicate that IRF-2 contributes to transcriptional activation of the NMHC-A gene via 32kb-150 during TPA-induced differentiation of HL-60 cells...
- Transforming growth factor-beta1 regulates cell growth and causes downregulation of SMemb/non-muscle myosin heavy chain B mRNA in human prostate stromal cellsKenji Obara
Department of Regenerative and Transplant Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
Scand J Urol Nephrol 39:366-71. 2005..The expression of the SM2 isoform of smooth muscle myosin heavy chain (SMMHC) mRNA was also examined...
- Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermatesGeorge E Georges
Department of Medicine, University of Washington, Seattle, Washington 98109 1024, USA
Biol Blood Marrow Transplant 9:234-42. 2003Donor cytotoxic T lymphocytes (CTL) specific for minor histocompatibility antigens (mHA) mediate the graft-versus-host effect whereas host mHA-specific CTL mediate graft rejection in the setting of major histocompatibility complex ..
- MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?Jeffrey B Kopp
Kidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892 1268, USA
Semin Nephrol 30:409-17. 2010Genetic variation in MYH9, encoding nonmuscle myosin IIA heavy chain, has been associated recently with increased risk for kidney disease...
- Cloning and developmental expression of nonmuscle myosin IIA (Myh9) in the mammalian inner earAnand N Mhatre
Department of Otolaryngology Head and Neck Surgery, University of California San Francisco, San Francisco, California, USA
J Neurosci Res 76:296-305. 2004b>MYH9 encoding a nonmuscle myosin heavy chain has been linked to nonsyndromic and syndromic forms of autosomal dominant hereditary hearing loss, suggesting a critical biological role of this motor protein in the auditory organ...
- The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathwayZhao Chen
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
Blood 110:171-9. 2007The gene implicated in the May-Hegglin anomaly and related macrothrombocytopenias, MYH9, encodes myosin-IIA, a protein that enables morphogenesis in diverse cell types...
- [A non-familial May-Hegglin anomaly accompanying with MYH9 gene R1933X mutation and I1626V polymorphism]Ying Li
Department of Hematology, Second Xiangya Hospital, Central South University, Changsha 410011, China
Zhonghua Xue Ye Xue Za Zhi 30:577-81. 2009To identify the nonmuscle myosin heavy chain 9 (MYH9) gene mutation site in a May-Hegglin anomaly(MHA) patient, and to analyze the genotype of her relatives to exclude the inherit correlation between the proband and her family members.
- [Usefulness of immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A for diagnosing in two sisters with May-Hegglin anomaly]Noriko Kimura
Department of Laboratory Medicine, Nara City Hospital, Japan
Rinsho Ketsueki 49:1614-8. 2008..MHA is caused by mutations in the MYH9 gene, which encodes the nonmuscle mysosin heavy chain-A (NMMCH-A)...
- A notable case report of May-Hegglin anomaly with immune complex-related nephropathy: a genetic and histological analysisY Ohtsuka
Department of Pediatrics, Faculty of Medicine, Saga University, Saga City, Japan
Clin Nephrol 75:255-62. 2011..Mutations in the MYH9 gene, encoding non-muscle myosin heavy chain IIA (NMMHC-IIA) have been identified in patients with MHA and other ..
- Kappa immunoglobulin light chain polymorphisms and survival after allogeneic transplantation for B-cell malignancies: a potential graft-vs-leukaemia targetT L Etto
Bone Marrow Transplant Programme, Alfred Hospital, Melbourne, Australia
Tissue Antigens 69:56-61. 2007..antigen (HLA)-matched haematopoietic stem cell transplantation (HSCT) setting, minor histocompatibility antigen (mHA) disparities between recipient and donor can lead to graft-vs-host disease (GVHD) or graft rejection...
- Expression of Myh9 in the mammalian cochlea: localization within the stereociliaAnand N Mhatre
Laboratory of Molecular Otology, Department of Otolaryngology, New York University School of Medicine, New York, New York 10016, USA
J Neurosci Res 84:809-18. 2006Mutations of non-muscle myosin Type IIA or MYH9 are linked to syndromic or nonsyndromic hearing loss. The biologic function of MYH9 in the auditory organ and the pathophysiology of its dysfunction remain to be determined...
- Regulated proteolysis of nonmuscle myosin IIA stimulates osteoclast fusionBrooke K McMichael
Department of Physiology and Cell Biology, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA
J Biol Chem 284:12266-75. 2009The nonmuscle myosin IIA heavy chain (Myh9) is strongly associated with adhesion structures of osteoclasts...
- Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytesSima Babayeva
Department of Medicine, McGill University, 3775 University Street, Montreal, QC, H3A2B4, Canada
Pediatr Nephrol 26:1071-81. 2011The MYH9 gene encodes a non-muscle myosin IIA heavy chain (NMMHC-IIA) expressed in podocytes...
- MeniÃ¨re's disease as a late manifestation of congenital syphilisF Indesteege
ENT Department, Middelheim General Hospital, Antwerp, Belgium
Acta Otorhinolaryngol Belg 43:327-33. 1989..The value of a positive serological test (FTA - ABS or MHA - T.P.) in the presence of inner-ear symptoms is discussed.
- Evaluation of an enzyme immunoassay technique for detection of antibodies against Treponema pallidumRita Castro
Unidade de Doenças Sexualmente Transmitidas, Centro de Malaria e Outras Doencas Tropicais, Instituto de Higiene e Medicina Tropical, Lisbon, Portugal
J Clin Microbiol 41:250-3. 2003..were 100 and 93%, respectively, compared with the results of a microhemagglutination assay for Treponema pallidum (MHA-TP) and 99...
- Floccular modulation of vestibuloocular pathways and cerebellum-related plasticity: An in vitro whole brain studyA L Babalian
Laboratoire de la Neurobiologie des Réseaux Sensorimoteures, Centre National de la Recherche Scientifique, 75270 Paris Cedex 06, France
J Neurophysiol 84:2514-28. 2000..responses in abducens and oculomotor nerves and abducens nucleus; for identification of flocculus target neurons (FTNs) in the vestibular nuclei and intracellular study of some of their physiological properties; to search for possible ..
- Use of a novel serum ELISA method and the tonsil-carrier state for evaluation of Mycoplasma hyosynoviae distributions in pig herds with or without clinical arthritisElisabeth Okholm Nielsen
The National Committee for Pig Production, Danish Bacon and Meat Council, Axeltorv 3, 1609 Copenhagen V, Denmark
Vet Microbiol 111:41-50. 2005..hyosynoviae arthritis (MhA herds, n = 4) and in herds with M...
- Of mice and men: Relevance of cellular and molecular characterizations of myosin IIA to MYH9-related human diseaseSharona Even-Ram
The Stem Cell Center, Goldyn Savad Institute of Gene Therapy, Hadassah University Hospital, Jerusalem, Israel
Cell Adh Migr 1:152-5. 2007..In humans, various mutations in the MYH9 gene that encodes the myosin IIA heavy chain cause autosomal dominant disease, whereas in mice, the complete ..
- [Expression and function of non-muscle myosin-IIA in Fechtner syndrome]Hai yan Yang
Ministry of Health, Jiangsu Institute of Hematology, The First Hospital of Suzhou University, Suzhou 215006, Jiagnsu Province, China
Zhongguo Shi Yan Xue Ye Xue Za Zhi 16:871-4. 2008..IIA and IIB show obvious interaction, IIB partly compensates the IIA defect derived from MYH9 mutations, and may delay or prevent the development of clinically relevant abnormalities.
- MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotypeAlessandro Pecci
Department of Internal Medicine, University of Pavia and IRCCS Policlinico San Matteo Foundation, Pavia
Eur J Haematol 84:291-7. 2010b>MYH9-related disease (MYH9-RD) is a rare autosomal dominant disorder caused by mutations in MYH9, the gene encoding the heavy chain of non-muscle myosin IIA...
- [Performance of different methods of oxacillin resistance detection in atypic strains of Staphylococcus aureus]F Hamdad
Service de Bacteriologie Hygiene, CHU d Amiens, France
Pathol Biol (Paris) 54:447-52. 2006..The diffusion method using the 5 microg oxacillin and 30 microg cefoxitin discs on Mueller-Hinton Agar (MHA) with and without NaCl, the incubation at 35 degrees C or 30 degrees C for 24 or 48 hours respectively, and the ..
- Cerebrospinal fluid treponemal antibodies in untreated early syphilisC M Marra
Department of Medicine, University of Washington, Seattle
Arch Neurol 52:68-72. 1995..cell count, protein, VDRL test, and antibodies to Treponema pallidum by microhemagglutination test for T pallidum (MHA-TP) and fluorescent treponemal antibody absorption test (FTA-ABS); albumin ratio; and IgG index...
- On-column derivatization-capillary electrochromatography with o-phthalaldehyde/alkylthiol for assay of biogenic aminesShigeyuki Oguri
Laboratory of Food Science, Department of Home Economics, Aichi Gakusen University, 28 Kamikawanari, Hegoshi cho, Okazaki City 444 8520, Japan
J Chromatogr A 1044:271-6. 2004The elution behaviors of the biogenic amines, histamine (HA) and its metabolite methyl histamine (MHA), were evaluated by means of on-column derivatization (OCD)-capillary electrochromatography (CEC) which employed a monolithic ..
- Prevalence of neurosyphilis in human immunodeficiency virus-infected patients with latent syphilisP D Holtom
Los Angeles County University of Southern California Medical Center 90033
Am J Med 93:9-12. 1992..with latent syphilis (reactive serum rapid plasma reagin [RPR] and microhemagglutination-Treponema pallidum [MHA-TP])...
- Cellular and Molecular Regulation of ThrombopoiesisRamesh A Shivdasani; Fiscal Year: 2012..biological studies, genetic analysis in mice, and appreciation of congenital human thrombocytopenias such as the Myh9- related disorders...
- Ali G Gharavi; Fiscal Year: 2014..complex determination, with significant contribution from genetic variation in the nonmuscle myosin heavy chain 9 (MYH9), a podocyte expressed gene...
- RNA profiling of HIV-associated nephropathy in patients with the MYH9 risk allelePAUL EVAN KLOTMAN; Fiscal Year: 2010..Recent Genome-wide analyses have identified a strong association of the gene MYH9, which encodes non-muscle myosin heavy chain IIA (Myosin-9), with idiopathic and HIV-associated FSGS in African-..
- Laura S Gammill; Fiscal Year: 2014..a first step in revealing the mechanism of this requirement, two-hybrid screening identified myosin heavy chain 9 (MYH9) as a candidate phosphorylation-dependent target of Paladin...
- Cellular Regulation of Dictyostelium Myosin Heavy Chain KinasesPaul A Steimle; Fiscal Year: 2012..turnover can lead to abnormal platelet formation, glomerulonephritis, among other pathologies associated with MYH9-related disorders...
- Genetic Determinants of Susceptibility to Kidney Disease in African AmericansThomas M Coffman; Fiscal Year: 2010..Recent studies have identified polymorphisms in the gene encoding MYH9, a non-muscle myosin heavy chain that are associated with susceptibility to ESRD in African-Americans, explaining a ..
- Actomyosin-Based Podocyte Contractility and Glomerular PathobiologyJoel M Henderson; Fiscal Year: 2012..aim will be to develop a transgenic mouse model that fails to express a specific isoform of myosin heavy chain, Myh9, in a podocyte-specific fashion and under temporal control...
- The role of autoimmune natural IgM in human myocardial infarctionMing Zhang; Fiscal Year: 2010..PUBLIC HEALTH RELEVANCE This study will provide important insight of a new mechanism in ischemic myocardial injury, and may identify new markers for myocardial infarction. ..
- Genome-wide Identification of Minor Histocompatibility AntigensShoudan Liang; Fiscal Year: 2012..best correlate with long-term remission, using existing and newly developed methods;and (3) experimentally verify mHA-HLA binding by tetramer technique, and verify leukemia-specific lysis by CTL cytotoxicity assay...
- James C Zimring; Fiscal Year: 2015..These studies have the potential to directly benefit patient populations who require platelet transfusions and subsequent BMT. ..
- Patricio E Ray; Fiscal Year: 2016..screened for the presence of the HIV-genome, HBGF, HSPG, and genotyped to characterize a genetic variation in the MYH9 gene, encoding the non-muscle myosin IIA heavy chain, that is associated with HIV-collapsing glomerulopathy in ..
- A National Consortium to Explore the Genotypic Basis for ESRD in LupusRobert P Kimberly; Fiscal Year: 2010..in SLE-related ESRD suggest that at least two genetic factors, -- certain allelic variants of the genes FCGR3A and MYH9, -- contribute to ESRD risk. However, two genes alone do not define the scope of genetic risk for ESRD...
- PAUL MICHAEL ARMISTEAD; Fiscal Year: 2014..at the computational predication of leukemia stem cell associated minor histocompatibility antigens (LSC-associated mHA). Dr...
- The role of complement system in alloimmune responsesQing Ma; Fiscal Year: 2013..GVHD), a result of alloimmune responses elicited by donor T lymphocytes to major and minor antigens (mHA). The disease is characterized primarily by targeted epithelial cell injury in skin, intestine and liver...
- AKINLOLU OLUSEUN OJO; Fiscal Year: 2016..g., MYH9 and AP0L1) and kidney disease...
- Natural History of MYH9-Associated NephropathyBARRY IRA FREEDMAN; Fiscal Year: 2012..This application proposes to determine the natural history of MYH9-associated HN in African Americans, as MYH9 accounts for 70% of all non- diabetic cases of end-stage renal disease (..
- Collaborative Model Addressing Mental Health in the Perinatal PeriodCynthia D Connelly; Fiscal Year: 2012..Utilizing a standardized instrument and a centralized Mental Health Advisor (MHA) to support providers and proactively contact depressed women, early recognition and treatment of MD will benefit ..
- Harish Vasudevan; Fiscal Year: 2015..In addition, many transcriptional targets of SRF (ActB, FlnA, and MyH9) are implicated in human craniofacial development...
- Identification of Minor Histocompatibility AntigensDavid Miklos; Fiscal Year: 2006DESCRIPTION (provided by applicant): Minor histocompatibility antigens (mHA) are peptides derived from normal cellular proteins that are presented by major histocompatibility antigen (MHC) class I and class H molecules...
- Mechanisms of GVHDJoseph Antin; Fiscal Year: 2007..data on immune reconstitution, chimerism, lymphocyte adhesion/migration, and minor histocompatibility antigens (mHA) recognition with patient outcomes...
- David Salkever; Fiscal Year: 2014..the implementation and diffusion of IPS-SE services, undertaken by the Maryland Mental Hygiene Administration (MHA), began as a pilot project in 2002...
- Improving Inpatient Psychiatric Payment: Cost and Quality ImplicationsDONALD MICHAEL STEINWACHS; Fiscal Year: 2010..the State of Maryland Health Services Cost Review Commission (HSCRC) and Maryland Mental Hygiene Administration (MHA)...
- Burden of Chronic Kidney Disease in HIV InfectionMichelle M Estrella; Fiscal Year: 2013..of kidney function;3) an investigation of the risk of CKD development and progression related to HAART and HIV disease stage;and 4) a validation of the association of MYH9 with CKD progression and specific renal histopathologic findings.
- Corey S Cutler; Fiscal Year: 2016..to HY antigens are important in cGVHD physiology underscores the need to develop more tools to identify somatic mHA as a step toward the integration of mHA and genetic determinates of immune reactivity...
- IMPROVING MENTAL HEALTH STATISTICS IN MARYLANDTIMOTHY SANTONI; Fiscal Year: 1991..New reporting and system requirements will be prepared, and local agencies will be given MHA consultation and funding to meet these revised, expanded requirements...
- IMPROVING MENTAL HEALTH STATISTICS IN MARYLANDTIMOTHY SANTONI; Fiscal Year: 1992..New reporting and system requirements will be prepared, and local agencies will be given MHA consultation and funding to meet these revised, expanded requirements...
- Maryland Science to Service for Children and FamiliesALBERT ZACHIK; Fiscal Year: 2003..This grant will expand the capacity of the Mental Hygiene Administration (MHA)-sponsored Systems Evaluation Center at the University of Maryland Department of Psychiatry - which is already ..
- Statewide Efforts to Improve Care in Intensive Care UnitPeter Pronovost; Fiscal Year: 2004..To implement these aims, we will develop interventions for MHA who will then interact with Michigan hospitals to implement these interventions...
- Role of Conventional Myosin MYH9 in HearingAnil Lalwani; Fiscal Year: 2006Through the candidate gene approach, we have identified MYH9 as the causative gene responsible for DFNA17, an autosomal dominant nonsyndromic form of hereditary hearing impairment...
- NIMH/M-RISP: ADVANCING RESEARCH IN PUERTO RICOGuillermo Bernal; Fiscal Year: 2007..faculty members in conducting pilot work leading to a competitive research grant on mental health and HIV/AIDS (MHA) problems, especially interventions and outcome research; (2) increasing the participation of graduate and ..
- NEUROSYPHILIS AND AIDS--PCR METHOD TO DETECT T. PALLIDUMLionel Resnick; Fiscal Year: 1993..In addition, individuals with HIV infection have been documented to lose their treponemal test reactivity to MHA-TP and FTA-ABS. Therefore, the need for the development of more effective methods to detect T. pallidum exists...
- High School COR Research Training for HispanicWANDA RODRIGUEZ AROCHO; Fiscal Year: 2006..of well-trained Hispanics in biomedical and behavioral research careers in the field of mental health and HIV-AIDS (MHA)...
- Continuation of the FIND StudyBarry Freedman; Fiscal Year: 2006..of genes that cause diabetic complications will take us one step closer to finding treatments that may have the potential to slow or prevent the development of these serious complications of diabetes mellitus [unreadable] [unreadable]..
- GENETIC ANALYSIS OF HUMAN HYPERTENSIVE ESRDBarry Freedman; Fiscal Year: 2001..The identification of hypertension-associated renal failure genes would form a genetic basis for detection of high risk individuals and development of intervention and treatment strategies for prevention of H-ESRD. ..
- Micro-Western Blot for Proteomics StudiesDavid Wallace; Fiscal Year: 2006..In circumstances where a protein sample is limited or the source of the antibody is rare or expensive, the Micro-Western blot method will provide a powerful alternative to conventional Western blotting methods. [unreadable] [unreadable]..
- Cytokines for Immune Protection from Acute IrradiationGeorge Georges; Fiscal Year: 2005..The secondary endpoint is immune reconstitution. Upon study completion, we will have identified the optimal cytokine treatment and the highest dose of TBI that can be reliably survived without HSC support. ..
- Gene Modified Donor T Cell Infusion into Mixed ChimerasGeorge Georges; Fiscal Year: 2003..If successful, this study could translate into improved control of the GVH reaction and improved survival after allogeneic HCT. ..
- GENE MODIFIED T-CELLS FOR ENGRAFTMENT AND GVHD CONTROLGeorge Georges; Fiscal Year: 2003..We will test if donor CTL specific for host minor histocompatibility antigens can convert mixed to complete donor chimerism. If successful this would make MHC-matched stem cell transplantation less toxic. ..
- Immunosupression-Resistant Gene Modified Donor T CellsGeorge Georges; Fiscal Year: 2009..Results from these studies have the strong potential to be directly translated to future gene therapy clinical trials. ..
- Improving Platelet Recovery After RadiationGeorge Georges; Fiscal Year: 2008..unreadable] [unreadable] [unreadable] [unreadable]..
- Improving Gastrointestinal Recovery after RadiationGeorge Georges; Fiscal Year: 2007..unreadable] [unreadable] [unreadable] [unreadable]..
- Neurobehavioral Regulation of Cigarette CravingsBrian Hitsman; Fiscal Year: 2008..abstract_text> ..
- Hospital strategies to improve outcome performanceELIZABETH HOWE BRADLEY; Fiscal Year: 2010..We will work on dissemination strategies with CMS, JCAHO, American College of Cardiology (ACC), American Health Association (AHA), the Veteran's Administration (VA), and the VHA. ..
- REQUIREMENT FOR SENSITIVE T CELL RESPONSE TO ANTIGENMichael Dustin; Fiscal Year: 2005....
- GLOMERULAR PERMSELECTIVITY IN ALPORT SYNDROMEClifford Kashtan; Fiscal Year: 2004..This trial will compare urinary protein levels, kidney function, and renal structural changes in treated and untreated dogs. ..
- CD8 + CD75s + regulatory T cells in anti-tumor immunityJAMES ZIMRING; Fiscal Year: 2007..These aims propose to investigate the role that negative regulatory T cells play in the establishment of immunological tolerance to tumor antigens and the fashion in which their elimination can result in tumor rejection. ..
- PHYSIOLOGICAL CHEMISTRY OF INTEGRIN FUNCTIONMichael Dustin; Fiscal Year: 2007..These experiments should provide new insight into regulation of integrin function and identify potential therapeutic targets for regulation of leukocyte integrins. ..
- Appropriate Pneumococcal Vaccination in Infants in FijiFiona Russell; Fiscal Year: 2007..The results of this study will form the basis of an effectiveness evaluation following the pilot introduction of pneumococcal immunization into Fiji in 3-5 years time. [unreadable] [unreadable]..
- GENETIC ANALYSIS OF HEREDITARY MACROTHROMBOCYTOPENIASMichael Kelley; Fiscal Year: 2002..clinical syndromes characterized by giant platelets and thrombocytopenia that include May-Hegglin anomaly (MHA), Fechtner syndrome, and Sebastian syndrome...
- Transmucosal Intra-Oral Drug Delivery System for THCMahmoud Elsohly; Fiscal Year: 2003..abstract_text> ..
- Measurement of Hypoxia in Non Small Cell Lung CarcinomaMichael Kelley; Fiscal Year: 2003..We believe the data from this pilot study will be useful to design future study(ies) with clinical endpoints and to guide selection of subjects for novel hypoxia-directed therapies in patients with NSCLC...
- Induction of Immunological Tolerance for Gene TherapyJAMES ZIMRING; Fiscal Year: 2008..unreadable] [unreadable] [unreadable] [unreadable] [unreadable]..
- SURFACE ANTIGENS OF TREPONEMA PALLIDUMWesley Van Voorhis; Fiscal Year: 2008..Finally, these studies will help define the protective immune response that results after immunization with Tp92 as well as the immune response to Tp92 that occurs during infection. [unreadable] [unreadable]..
- Phase I/II Trial of ZD1839 and Celecoxib in Ex-SmokersMichael Kelley; Fiscal Year: 2006..abstract_text> ..
- Admixture Mapping to Identify T2DM Genes in African AmericansWen Hong Kao; Fiscal Year: 2007..unreadable] [unreadable] [unreadable]..
- The role of Ach in CD8+ Cytolytic T cell developmentJAMES ZIMRING; Fiscal Year: 2005..abstract_text> ..
- Selective depletion of alloreactive T cells in BMTJAMES ZIMRING; Fiscal Year: 2005..In keeping with the stated purpose of this RFA, these studies represent the "development and application of cell engineering methods to predictably induce tolerance..." ..
- Randomized Trial of Rosiglitazone for Ulcerative ColitisJames Lewis; Fiscal Year: 2005..If our hypothesis is correct, this study will serve to establish that ligands for PPARg possess biological activity necessary to modulate the inflammatory response in the intact human colon. ..
- Identification of Genes for ESRD in African AmericansWen Hong Kao; Fiscal Year: 2007..This study will provide key insights into the genetic control of susceptibility of ESRD [unreadable] [unreadable]..
- Compositions for Prevention/Prophylactic Treatment of Poison Ivy DermatitisMahmoud Elsohly; Fiscal Year: 2006..This proposal addresses a major public health problem, namely contact allergic dermatitis and promises the development of an effective agent to address this problem. [unreadable] [unreadable]..
- Alloimmunization to mHAs by RBC TransfusionJAMES ZIMRING; Fiscal Year: 2007..provides a mechanism by which chronic transfusion of even stringently leukoreduced RBC may result in sufficient mHA immunization to increase the frequency of BMT rejection...
- Association of PPAR gamma ligands & colonic neoplasiaJames Lewis; Fiscal Year: 2006..Our results will allow us to translate the existing in vitro and in vivo observations to the intact human colon and could lead to further chemoprevention strategies. ..
- For-Profit Ownership and End-of-Life CareElizabeth Bradley; Fiscal Year: 2009..Relevance in lay language: We will generate knowledge about the influence of for-profit hospice ownership on the experiences of patients with cancer and their families. ..